Evidence map›Paper›PMID 29410050›Full record

ArticleExperimental hematology2018

High-throughput single-cell fate potential assay of murine hematopoietic progenitors in vitro.

Betsabeh Khoramian Tusi, Merav Socolovsky

Abstract read
In one paragraph

Article in Experimental hematology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Betsabeh Khoramian TusiDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts.
Merav SocolovskyDepartment of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts; Department of Pediatrics, Hematology/Oncology Division, University of Massachusetts Medical School, Worcester, Massachusetts. Electronic address: merav.socolovsky@umassmed.edu.

Funding

Epigenetic and Cell Cycle Functions of Glucocorticoids in Erythropoietic StressR01DK100915 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SOCOLOVSKY, MERAV · 2014 to 2018
$1.8M
DNA Replication and Genome-Wide Demethylation in ErythropoiesisR01DK099281 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SOCOLOVSKY, MERAV · 2013 to 2016
$1.5M
NIDDK NIH HHS R01 DK099281NIDDK NIH HHS R01 DK100915
6 · The paper itself

Abstract

The advent of single-cell transcriptomics has led to the proposal of a number of novel high-resolution models for the hematopoietic system. Testing the predictions generated by such models requires cell fate potential assays of matching, single-cell resolution. Here we detail the development of an in vitro high-throughput single-cell culture assay using flow cytometrically sorted single murine bone marrow progenitors, which measures their differentiation into any of five myeloid lineages. We identify critical parameters for single-cell culture outcome, including the choice of sorter nozzle size and pressure, culture media, and the coating of culture dishes with extracellular matrix proteins. Further, we find that accurate assay readout requires the titration of antibodies specifically for their use under low-cell-number conditions. Our approach may be used as a template for the development of single-cell fate potential assays for a variety of blood cell progenitors.

Indexed as

AnimalsCell Culture TechniquesFemaleGene Expression ProfilingHematopoietic Stem CellsMaleMiceMice, Inbred BALB C

Identifiers

PMID29410050
PMCPMC5857247

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.